Pharmafile Logo

B2B sales

- PMLiVE

Rubica appoints former GSK executive communications and engagement lead

Caroline Gosling becomes Rubica’s director of culture and engagement

- PMLiVE

Six new national standards are launched across UK

Will help to improve public involvement in research says ABPI’s Mike Thompson

- PMLiVE

Therachon poaches Shire’s Aled Williams

He becomes the biotech’s chief commercial officer and head of patient access

- PMLiVE

Sun Pharma passes milestone with novel psoriasis drug approval

Ilumya will treat adults with a moderate-to-severe form of the skin condition

Celgene building

Celgene bulks up pipeline again with $2.1bn Prothena deal

Acquires candidates with potential in Alzheimer’s, ALS and dementia

- PMLiVE

IMI calls for advancements in machine learning and digital clinical trials

Will reserve up to €82m for universities, SMEs and patient organisations

- PMLiVE

McCann Health promotes Briana Ferrigno to president of McCann Global Health

She will drive growth and diversification of the agency’s portfolio

- PMLiVE

Apitope strengthens its board with new director

Dr William Jenkins joins the board following a 30-year career in clinical medicine

Bayer looks to leverage AI across the pharma value chain

Dieter Weinand outlines his hopes for applying artificial intelligence

- PMLiVE

Seattle Genetics claims key US approval for Adcetris

Becomes the first new treatment for advanced Hl in more than 40 years

- PMLiVE

Healthcare sector ‘lacks awareness’ of cybersecurity threats

RAE report suggests medical devices could be prone to cyber attacks

- PMLiVE

Ogilvy and Pulsar reveals latest ‘social check-up’ report

Social media report names Novo Nordisk as most engaging pharma company

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links